TTLL4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.284800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.282000E-01
Normal-vs-Stage2
7.822600E-01
Normal-vs-Stage3
4.539000E-01
Normal-vs-Stage4
9.534800E-01
Stage1-vs-Stage2
5.244000E-01
Stage1-vs-Stage3
4.752600E-01
Stage1-vs-Stage4
7.955200E-01
Stage2-vs-Stage3
1.703970E-01
Stage2-vs-Stage4
7.963000E-01
Stage3-vs-Stage4
4.360800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.692600E-01
Normal-vs-AfricanAmerican
6.758400E-01
Normal-vs-Asian
4.416800E-01
Caucasian-vs-AfricanAmerican
6.635800E-01
Caucasian-vs-Asian
1.360810E-01
AfricanAmerican-vs-Asian
5.591000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.500800E-01
Normal-vs-Female
9.738600E-01
Male-vs-Female
4.038800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.853400E-01
Normal-vs-Age(41-60Yrs)
7.098600E-01
Normal-vs-Age(61-80Yrs)
9.544600E-01
Normal-vs-Age(81-100Yrs)
7.531800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.630800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.242600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.075800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.159430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.542200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.162400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.350200E-01
Normal-vs-Daily Drinker
5.602400E-01
Normal-vs-Weekly Drinker
6.970600E-01
Normal-vs-Occasional Drinker
7.214400E-01
Normal-vs-Social Drinker
9.330600E-01
Non Drinker-vs-Daily Drinker
3.132200E-01
Non Drinker-vs-Weekly Drinker
3.320400E-01
Non Drinker-vs-Occasional Drinker
3.824400E-01
Non Drinker-vs-Social Drinker
7.467800E-01
Daily Drinker-vs-Weekly Drinker
9.800500E-02
Daily Drinker-vs-Occasional Drinker
8.621900E-02
Daily Drinker-vs-Social Drinker
2.988600E-01
Weekly Drinker-vs-Occasional Drinker
8.376600E-01
Weekly Drinker-vs-Social Drinker
6.382200E-01
Occasional Drinker-vs-Social Drinker
7.202400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.020200E-01
Normal-vs-Grade 2
8.822800E-03
Normal-vs-Grade 3
3.343600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.441400E-04
Grade 1-vs-Grade 3
3.754900E-04
Grade 1-vs-Grade 4
1.020200E-01
Grade 2-vs-Grade 3
1.957180E-01
Grade 2-vs-Grade 4
8.822800E-03
Grade 3-vs-Grade 4
3.343600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.275600E-01
Normal-vs-NonDiabetic
8.745800E-01
Diabetic-vs-NonDiabetic
1.270590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.246400E-01
Normal-vs-NoPancreatitis
9.041200E-01
Pancreatitis-vs-NoPancreatitis
4.044700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.908400E-01
Normal-vs-N1
8.663800E-01
N0-vs-N1
6.074000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.756500E-02
Normal-vs-TP53-NonMutant
3.070600E-01
TP53-Mutant-vs-TP53-NonMutant
3.260800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
